These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 24061483
1. NRG3 gene is associated with the risk and age at onset of Alzheimer disease. Wang KS, Xu N, Wang L, Aragon L, Ciubuc R, Arana TB, Mao C, Petty L, Briones D, Su BB, Luo X, Camarillo C, Escamilla MA, Xu C. J Neural Transm (Vienna); 2014 Feb; 121(2):183-92. PubMed ID: 24061483 [Abstract] [Full Text] [Related]
2. Family-based association analysis of NAV2 gene with the risk and age at onset of Alzheimer's disease. Wang KS, Liu Y, Xu C, Liu X, Luo X. J Neuroimmunol; 2017 Sep 15; 310():60-65. PubMed ID: 28778446 [Abstract] [Full Text] [Related]
3. Analysis of PTPRK polymorphisms in association with risk and age at onset of Alzheimer's disease, cancer risk, and cholesterol. Chen Y, Xu C, Harirforoosh S, Luo X, Wang KS. J Psychiatr Res; 2018 Jan 15; 96():65-72. PubMed ID: 28987514 [Abstract] [Full Text] [Related]
4. Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Kao WT, Wang Y, Kleinman JE, Lipska BK, Hyde TM, Weinberger DR, Law AJ. Proc Natl Acad Sci U S A; 2010 Aug 31; 107(35):15619-24. PubMed ID: 20713722 [Abstract] [Full Text] [Related]
5. Polymorphisms within ASTN2 gene are associated with age at onset of Alzheimer's disease. Wang KS, Tonarelli S, Luo X, Wang L, Su B, Zuo L, Mao C, Rubin L, Briones D, Xu C. J Neural Transm (Vienna); 2015 May 31; 122(5):701-8. PubMed ID: 25410587 [Abstract] [Full Text] [Related]
6. Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures. Kamboh MI, Minster RL, Feingold E, DeKosky ST. Mol Psychiatry; 2006 Mar 31; 11(3):273-9. PubMed ID: 16302009 [Abstract] [Full Text] [Related]
7. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, Baldwin CT, Jarvik GP, Crane PK, Rogaeva E, Barmada MM, Demirci FY, Cruchaga C, Kramer PL, Ertekin-Taner N, Hardy J, Graff-Radford NR, Green RC, Larson EB, St George-Hyslop PH, Buxbaum JD, Evans DA, Schneider JA, Lunetta KL, Kamboh MI, Saykin AJ, Reiman EM, De Jager PL, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Martin ER, Haines JL, Mayeux RP, Farrer LA, Schellenberg GD, Pericak-Vance MA, Alzheimer Disease Genetics Consortium, Albert MS, Albin RL, Apostolova LG, Arnold SE, Barber R, Barnes LL, Beach TG, Becker JT, Beekly D, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carney RM, Carrasquillo MM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cribbs DH, Crocco EA, DeCarli C, DeKosky ST, Dick M, Dickson DW, Duara R, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lin CF, Lopez OL, Lyketsos CG, Mack WJ, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Murrell JR, Olichney JM, Pankratz VS, Parisi JE, Paulson HL, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Valladares O, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Wishnek S, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu L. JAMA Neurol; 2014 Nov 31; 71(11):1394-404. PubMed ID: 25199842 [Abstract] [Full Text] [Related]
8. Family-based genome scan for age at onset of late-onset Alzheimer's disease in whole exome sequencing data. Saad M, Brkanac Z, Wijsman EM. Genes Brain Behav; 2015 Nov 31; 14(8):607-17. PubMed ID: 26394601 [Abstract] [Full Text] [Related]
9. Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence. Turner JR, Ray R, Lee B, Everett L, Xiang J, Jepson C, Kaestner KH, Lerman C, Blendy JA. Mol Psychiatry; 2014 Jul 31; 19(7):801-10. PubMed ID: 23999525 [Abstract] [Full Text] [Related]
10. Non-parametric Survival Analysis of EPG5 Gene with Age at Onset of Alzheimer's Disease. Wang KS, Liu X, Xie C, Liu Y, Xu C. J Mol Neurosci; 2016 Dec 31; 60(4):436-444. PubMed ID: 27586004 [Abstract] [Full Text] [Related]
11. Polymorphisms in glutathione S-transferase omega-1 gene and increased risk of sporadic Alzheimer disease. Capurso C, Panza F, Seripa D, Frisardi V, Imbimbo BP, Verdile G, Vendemiale G, Pilotto A, Solfrizzi V. Rejuvenation Res; 2010 Dec 31; 13(6):645-52. PubMed ID: 20818931 [Abstract] [Full Text] [Related]
12. Polymorphisms of the estrogen receptor alpha (ESR1) gene and the risk of Alzheimer's disease in a southern Chinese community. Ma SL, Tang NL, Tam CW, Lui VW, Lau ES, Zhang YP, Chiu HF, Lam LC. Int Psychogeriatr; 2009 Oct 31; 21(5):977-86. PubMed ID: 19586561 [Abstract] [Full Text] [Related]
13. Genome-wide association analysis of age-at-onset in Alzheimer's disease. Kamboh MI, Barmada MM, Demirci FY, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ, Alzheimer's Disease Neuroimaging Initiative, Sweet RA, Feingold E, DeKosky ST, Lopez OL. Mol Psychiatry; 2012 Dec 31; 17(12):1340-6. PubMed ID: 22005931 [Abstract] [Full Text] [Related]
14. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease. Ozturk A, DeKosky ST, Kamboh MI. Neurobiol Aging; 2006 Oct 31; 27(10):1440-4. PubMed ID: 16223550 [Abstract] [Full Text] [Related]
15. Association of NRG3 and ERBB4 gene polymorphism with nicotine dependence in Turkish population. Kara HG, Erdal ME, Yılmaz SG, Şengül C, Şengül CB, Karakülah K. Mol Biol Rep; 2021 Jun 31; 48(6):5319-5326. PubMed ID: 34247340 [Abstract] [Full Text] [Related]
16. MxA polymorphisms are associated with risk and age-at-onset in Alzheimer disease and accelerated cognitive decline in Chinese elders. Ma SL, Huang W, Tang NL, Lam LC. Rejuvenation Res; 2012 Oct 31; 15(5):516-22. PubMed ID: 22950423 [Abstract] [Full Text] [Related]
17. Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease. Ozturk A, Desai PP, Minster RL, Dekosky ST, Kamboh MI. Neurobiol Aging; 2005 Oct 31; 26(8):1161-5. PubMed ID: 15917099 [Abstract] [Full Text] [Related]
18. Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease. Kamboh MI, Minster RL, Kenney M, Ozturk A, Desai PP, Kammerer CM, DeKosky ST. Neurobiol Aging; 2006 Oct 31; 27(10):1435-9. PubMed ID: 16137793 [Abstract] [Full Text] [Related]
19. Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease. Shi Z, Yu H, Wu Y, Ford M, Perschon C, Wang C, Zheng SL, Xu J. Clin Genet; 2019 Feb 31; 95(2):302-309. PubMed ID: 30460685 [Abstract] [Full Text] [Related]
20. Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition. Morar B, Dragović M, Waters FA, Chandler D, Kalaydjieva L, Jablensky A. Mol Psychiatry; 2011 Aug 31; 16(8):860-6. PubMed ID: 20548296 [Abstract] [Full Text] [Related] Page: [Next] [New Search]